Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HLCS | P50747 | 6/20 | 0.60 |
| ▸ | TDP1 | Q9NUW8 | 6/20 | 0.57 |
| ▸ | MEN1 | O00255 | 1/20 | 0.57 |
| ▸ | ABL1 | P00519 | 1/20 | 0.57 |
| ▸ | LMNA | P02545 | 1/20 | 0.57 |
| ▸ | PKM | P14618 | 1/20 | 0.57 |
| ▸ | IDE | P14735 | 1/20 | 0.57 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.57 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.57 |
| ▸ | RIN1 | Q13671 | 1/20 | 0.57 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.57 |
| ▸ | CA12 | O43570 | 5/20 | 0.41 |
| ▸ | CA1 | P00915 | 5/20 | 0.41 |
| ▸ | CA2 | P00918 | 5/20 | 0.41 |
| ▸ | CA9 | Q16790 | 5/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL425273 | 0.89 | TDP1 (0.67) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL31578494 | 0.85 | HLCS (0.45) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL4740139 | 0.83 | TDP1 (0.60) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL487045 | 0.82 | TDP1 (0.68) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL4454446 | 0.82 | TDP1 (0.58) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL1403829 | 0.82 | TDP1 (0.77) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL4466074 | 0.82 | HLCS (0.72) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL1527196 | 0.82 | TDP1 (0.58) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL3839854 | 0.82 | TDP1 (0.58) | HLCSTDP1MEN1ABL1LMNA | |
| SCHEMBL7122397 | 0.82 | TDP1 (0.61) | HLCSTDP1MEN1ABL1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114578043-B | ELISA kit, preparation method and detection method thereof | 伊莱瑞特(武汉)生物技术有限公司 | 2024-08-20 | — | — | CN | claimed |
| CN-114578043-A | ELISA kit and preparation method and detection method thereof | 伊莱瑞特(武汉)生物技术有限公司 | 2022-06-03 | — | — | CN | claimed |
| CN-114578043-A | ELISA kit and preparation method and detection method thereof | 伊莱瑞特(武汉)生物技术有限公司 | 2022-06-03 | — | — | CN | disclosed |
| US-20120083599-A1 | Biomolecular Labelling Using Multifunctional Biotin Analogues | UNIVERSITY OF NOTTINGHAM (GB) | 2012-04-05 | — | — | US | disclosed |
| US-20120083599-A1 | Biomolecular Labelling Using Multifunctional Biotin Analogues | UNIVERSITY OF NOTTINGHAM (GB) | 2012-04-05 | — | — | US | disclosed |
| US-20120083599-A1 | Biomolecular Labelling Using Multifunctional Biotin Analogues | UNIVERSITY OF NOTTINGHAM (GB) | 2012-04-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120083599-A1 | Biomolecular Labelling Using Multifunctional Biotin Analogues | BTD, URB2, RAET1L | HLCS 7/4885TDP1 4767/4885MEN1 3602/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.